Schedule 13G ownership disclosure

Vistagen Therapeutics Inc

Security class unavailable · CUSIP: 92840H400

Event date: 2023-10-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,565,829
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-005016
Form type
SC 13G
Filer
Point72 Asset Management, L.P.
CIK
CIK 1603466
Filed
Oct 05, 2023
Reporting period
Oct 04, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub